TY - JOUR
T1 - Cross-species analysis of FcγRIIa/b (CD32a/b) polymorphisms at position 131
T2 - structural and functional insights into the mechanism of IgG- mediated phagocytosis in human and macaque
AU - Tolbert, William D.
AU - Nhan, Paula B.
AU - Conley, Haleigh E.
AU - Ge, Xiaoxuan
AU - Chandravanshi, Monika
AU - Lee, Madeleine
AU - Veilleux, Julianna
AU - Korzeniowski, Marek
AU - Gottumukkala, Suneetha
AU - Ackerman, Margaret E.
AU - Pollara, Justin
AU - Pazgier, Marzena
N1 - Publisher Copyright:
Copyright © 2025 Tolbert, Nhan, Conley, Ge, Chandravanshi, Lee, Veilleux, Korzeniowski, Gottumukkala, Ackerman, Pollara and Pazgier.
PY - 2025
Y1 - 2025
N2 - Introduction: Antibodies play a critical role in immunity in part by mediating clearance of pathogens and infected cells by antibody-dependent cellular phagocytosis (ADCP) through engagement of Fc gamma receptors (FcγRs) on innate immune cells. Among these, FcγRIIa (CD32a) is a key activating receptor expressed on macrophages, dendritic cells, and other antigen-presenting cells. Its affinity for IgG and ability to mediate ADCP is influenced by allelic polymorphisms. In humans, a single amino acid polymorphism at position 131, where histidine (H) is substituted with arginine (R), leads to decreased IgG1 and IgG2 subclass binding affinity and, consequently, lower efficiency of phagocytic responses. Rhesus macaques (Macaca mulatta), which are widely used as nonhuman primate models, exhibit a similar polymorphism at position 131 of FcγRIIa, but with arginine replaced by proline (P). Here, we investigated structure-function relationships associated with the FcγRIIa polymorphism at position 131 in both species, specifically with respect to IgG1 and IgG2. Methods: We determined the structures of complexes formed by each variant with IgG1 Fc and those formed by the higher affinity variant with IgG2 Fc for both species by x-ray crystallography and linked these structures to affinity and activity using SPR and an ADCP assay. We also determined the structure of human inhibitory FcγRIIb (CD32b) in complex with IgG1 Fc by x-ray crystallography. Results: Through analysis of these structures, our studies reveal that FcγRIIa engagement is minimally influenced by Fc glycan composition, distinguishing it from FcγRIIIa whose affinity is strongly influenced by glycan-composition. Comparative structures of human and macaque FcγRIIa variants demonstrate species- and allele-specific differences in Fc binding, but our functional assays showed only minimal allele-specific effects in humans. In contrast, allele-specific effects in macaques were highly significant; the macaque P131 variant showing uniformly reduced IgG affinity. Conclusion: These insights highlight fundamental interspecies and allelic distinctions that are critical for interpreting FcγRIIa-mediated effector functions in macaque models and for optimizing translational antibody and vaccine design.
AB - Introduction: Antibodies play a critical role in immunity in part by mediating clearance of pathogens and infected cells by antibody-dependent cellular phagocytosis (ADCP) through engagement of Fc gamma receptors (FcγRs) on innate immune cells. Among these, FcγRIIa (CD32a) is a key activating receptor expressed on macrophages, dendritic cells, and other antigen-presenting cells. Its affinity for IgG and ability to mediate ADCP is influenced by allelic polymorphisms. In humans, a single amino acid polymorphism at position 131, where histidine (H) is substituted with arginine (R), leads to decreased IgG1 and IgG2 subclass binding affinity and, consequently, lower efficiency of phagocytic responses. Rhesus macaques (Macaca mulatta), which are widely used as nonhuman primate models, exhibit a similar polymorphism at position 131 of FcγRIIa, but with arginine replaced by proline (P). Here, we investigated structure-function relationships associated with the FcγRIIa polymorphism at position 131 in both species, specifically with respect to IgG1 and IgG2. Methods: We determined the structures of complexes formed by each variant with IgG1 Fc and those formed by the higher affinity variant with IgG2 Fc for both species by x-ray crystallography and linked these structures to affinity and activity using SPR and an ADCP assay. We also determined the structure of human inhibitory FcγRIIb (CD32b) in complex with IgG1 Fc by x-ray crystallography. Results: Through analysis of these structures, our studies reveal that FcγRIIa engagement is minimally influenced by Fc glycan composition, distinguishing it from FcγRIIIa whose affinity is strongly influenced by glycan-composition. Comparative structures of human and macaque FcγRIIa variants demonstrate species- and allele-specific differences in Fc binding, but our functional assays showed only minimal allele-specific effects in humans. In contrast, allele-specific effects in macaques were highly significant; the macaque P131 variant showing uniformly reduced IgG affinity. Conclusion: These insights highlight fundamental interspecies and allelic distinctions that are critical for interpreting FcγRIIa-mediated effector functions in macaque models and for optimizing translational antibody and vaccine design.
KW - CD32
KW - Fc-effector function
KW - FcγRIIa His/Arg131
KW - FcγRIIa His/Pro131
KW - IgG1(Fc)-FcγRII complex structure
KW - IgG2(Fc)-FcγRIIa complex structure
KW - human Homo sapiens
KW - rhesus macaque Macaca mulatta
UR - http://www.scopus.com/inward/record.url?scp=105025658110&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2025.1726068
DO - 10.3389/fimmu.2025.1726068
M3 - Article
C2 - 41445744
AN - SCOPUS:105025658110
SN - 1664-3224
VL - 16
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 1726068
ER -